180 related articles for article (PubMed ID: 12652343)
21. Involvement of purinergic signalling in central mechanisms of body temperature regulation in rats.
Gourine AV; Melenchuk EV; Poputnikov DM; Gourine VN; Spyer KM
Br J Pharmacol; 2002 Apr; 135(8):2047-55. PubMed ID: 11959809
[TBL] [Abstract][Full Text] [Related]
22. Evidence that rat hepatocytes co-express functional P2Y1 and P2Y2 receptors.
Dixon CJ; Woods NM; Webb TE; Green AK
Br J Pharmacol; 2000 Feb; 129(4):764-70. PubMed ID: 10683201
[TBL] [Abstract][Full Text] [Related]
23. Modulation of cyclooxygenase-2 and brain reactive astrogliosis by purinergic P2 receptors.
Brambilla R; Abbracchio MP
Ann N Y Acad Sci; 2001 Jun; 939():54-62. PubMed ID: 11462804
[TBL] [Abstract][Full Text] [Related]
24. Nucleotide-mediated calcium signaling in rat cortical astrocytes: Role of P2X and P2Y receptors.
Fumagalli M; Brambilla R; D'Ambrosi N; Volonté C; Matteoli M; Verderio C; Abbracchio MP
Glia; 2003 Sep; 43(3):218-03. PubMed ID: 12898701
[TBL] [Abstract][Full Text] [Related]
25. Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats.
Lämmer A; Günther A; Beck A; Krügel U; Kittner H; Schneider D; Illes P; Franke H
Eur J Neurosci; 2006 May; 23(10):2824-8. PubMed ID: 16817887
[TBL] [Abstract][Full Text] [Related]
26. Functional expression of ionotropic purinergic receptors on mouse taste bud cells.
Hayato R; Ohtubo Y; Yoshii K
J Physiol; 2007 Oct; 584(Pt 2):473-88. PubMed ID: 17702819
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of P2Y1 receptors causes anxiolytic-like effects in the rat elevated plus-maze: implications for the involvement of P2Y1 receptor-mediated nitric oxide production.
Kittner H; Franke H; Fischer W; Schultheis N; Krügel U; Illes P
Neuropsychopharmacology; 2003 Mar; 28(3):435-44. PubMed ID: 12629523
[TBL] [Abstract][Full Text] [Related]
28. Neurovascular unit alteration in somatosensory cortex and enhancement of thermal nociception induced by amphetamine involves central AT
Occhieppo VB; Marchese NA; Rodríguez ID; Basmadjian OM; Baiardi G; Bregonzio C
Eur J Neurosci; 2017 Jun; 45(12):1586-1593. PubMed ID: 28449313
[TBL] [Abstract][Full Text] [Related]
29. A novel gliotic P2 receptor mediating cyclooxygenase-2 induction in rat and human astrocytes.
Brambilla R; Ceruti S; Malorni W; Cattabeni F; Abbracchio MP
J Auton Nerv Syst; 2000 Jul; 81(1-3):3-9. PubMed ID: 10869693
[TBL] [Abstract][Full Text] [Related]
30. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
Rost S; Daniel C; Schulze-Lohoff E; Bäumert HG; Lambrecht G; Hugo C
Kidney Int; 2002 Nov; 62(5):1659-71. PubMed ID: 12371966
[TBL] [Abstract][Full Text] [Related]
31. Viability of SH-SY5Y cells is associated with purinergic P2 receptor expression alterations.
Örçen A; Yilmaz V; Giriş M; Akcan U; Tüzün E; Erten G
Acta Biol Hung; 2017 Mar; 68(1):22-34. PubMed ID: 28322086
[TBL] [Abstract][Full Text] [Related]
32. Role of ATP in fast excitatory synaptic potentials in locus coeruleus neurones of the rat.
Nieber K; Poelchen W; Illes P
Br J Pharmacol; 1997 Oct; 122(3):423-30. PubMed ID: 9351497
[TBL] [Abstract][Full Text] [Related]
33. Increase of intracellular Ca2+ by P2X and P2Y receptor-subtypes in cultured cortical astroglia of the rat.
Fischer W; Appelt K; Grohmann M; Franke H; Nörenberg W; Illes P
Neuroscience; 2009 Jun; 160(4):767-83. PubMed ID: 19289154
[TBL] [Abstract][Full Text] [Related]
34. Evidence for the involvement of endogenous ATP and P2X receptors in TMJ pain.
Oliveira MC; Parada CA; Veiga MC; Rodrigues LR; Barros SP; Tambeli CH
Eur J Pain; 2005 Feb; 9(1):87-93. PubMed ID: 15629879
[TBL] [Abstract][Full Text] [Related]
35. Evidence for the involvement of spinal endogenous ATP and P2X receptors in nociceptive responses caused by formalin and capsaicin in mice.
Tsuda M; Ueno S; Inoue K
Br J Pharmacol; 1999 Dec; 128(7):1497-504. PubMed ID: 10602329
[TBL] [Abstract][Full Text] [Related]
36. The P2 receptor antagonist PPADS supports recovery from experimental stroke in vivo.
Lämmer AB; Beck A; Grummich B; Förschler A; Krügel T; Kahn T; Schneider D; Illes P; Franke H; Krügel U
PLoS One; 2011; 6(5):e19983. PubMed ID: 21611146
[TBL] [Abstract][Full Text] [Related]
37. Ecto-nucleotide pyrophosphatase modulates the purinoceptor-mediated signal transduction and is inhibited by purinoceptor antagonists.
Grobben B; Claes P; Roymans D; Esmans EL; Van Onckelen H; Slegers H
Br J Pharmacol; 2000 May; 130(1):139-45. PubMed ID: 10781009
[TBL] [Abstract][Full Text] [Related]
38. Secretion of ATP from Schwann cells in response to uridine triphosphate.
Liu GJ; Werry EL; Bennett MR
Eur J Neurosci; 2005 Jan; 21(1):151-60. PubMed ID: 15654852
[TBL] [Abstract][Full Text] [Related]
39. Multiple motor effects of ATP and their inhibition by P purinoceptor antagonist, pyridoxalphosphate-6-azophenyl-2',4'-disulphonic acid in the small intestine of the guinea-pig.
Barthó L; Undi S; Benkó R; Wolf M; Lázár Z; Lénárd L; Maggi CA
Basic Clin Pharmacol Toxicol; 2006 May; 98(5):488-95. PubMed ID: 16635108
[TBL] [Abstract][Full Text] [Related]
40. Effects of P2Y1 receptor on glial fibrillary acidic protein and glial cell line-derived neurotrophic factor production of astrocytes under ischemic condition and the related signaling pathways.
Sun JJ; Liu Y; Ye ZR
Neurosci Bull; 2008 Aug; 24(4):231-43. PubMed ID: 18668152
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
